Global Cardiac Biomarker POCT Diagnostic Device Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Cardiac Biomarker POCT Diagnostic Device market size was valued at US$ 247 million in 2025 and is forecast to a readjusted size of US$ 382 million by 2032 with a CAGR of 6.2% during review period.
The Cardiac Biomarker POCT Diagnostic Device is designed for emergency departments, chest pain centers, intensive care units, cardiology outpatient clinics, primary care, and pre-hospital emergency use. It utilizes fluorescence immunoassay, chemiluminescence, and microfluidic technologies to measure cardiac injury markers including cTnI, hs-cTnI, cTnT, CK-MB, and myoglobin, as well as heart failure biomarkers BNP and NT-proBNP. Upstream materials include highly specific monoclonal antibodies, fluorescent labels, microfluidic chips, and dedicated consumables. The main customers are hospitals, emergency and chest pain centers, ICUs, cardiology clinics, primary care facilities, and pre-hospital emergency services worldwide. In 2025, global production capacity is approximately 26,500 units, with actual sales around 21,380 units, an average ex-factory price of 11,200 USD per unit, and a gross margin range of 38%?50%.
The global market for cardiac biomarker POCT diagnostic devices exhibits a multi-layered competitive structure, with high-end companies in North America, Europe, and Japan coexisting with mid-tier manufacturers in China and South Korea. Emergency departments, chest pain centers, and ICUs remain core application areas. Platforms have evolved from single-marker testing to high-sensitivity troponin, multi-marker panels, microfluidic, and fluorescence immunoassay technologies, creating a complete ecosystem of analyzers and reagent consumables. Manufacturers establish recurring revenue and customer stickiness through consumable binding, hospital data integration, and workflow coordination. Chinese and Korean companies expand market share through cost control, rapid product iteration, and export channels, while Western and Japanese leaders maintain technological and brand advantages in high-end hospital settings, also pushing the integration of high-sensitivity assays and connected data systems.
Future trends indicate continuous growth in platform-based, multi-marker testing and high-sensitivity troponin penetration. Next-generation devices will increasingly feature microfluidic chips, dry fluorescence assays, automated operation systems, portability, and networked functionality. Information integration and data management capabilities are becoming critical for platform competitiveness, driving optimization of emergency workflows, remote monitoring, and differentiated clinical decision support. Regionally, Chinese and Korean firms are rapidly expanding mid-tier and export markets, while Western and Japanese companies maintain leadership in high-end hospitals, forming a globally multi-tiered, regionally complementary market. Clinical validation and standardization of new technologies will further enhance device reliability and physician acceptance, supporting sustained market growth.
Market growth is primarily driven by strong clinical demand for rapid and high-precision testing. High-sensitivity assays and multi-marker panels optimize acute myocardial infarction triage, heart failure evaluation, and critical patient monitoring. Technological iteration and new product development not only enhance platform capabilities but also provide opportunities for market share expansion and improved gross margins. Downstream customers include hospitals, emergency and chest pain centers, ICUs, cardiology outpatient clinics, primary care facilities, and pre-hospital emergency services. Companies achieve sustainable revenue through device-consumable integration, client management, and service upgrades, establishing long-term competitive barriers in clinical protocols and hospital workflows.
Obstacles include stringent regulatory and clinical validation requirements, hospital procurement pacing, and constraints from reimbursement and payment systems. Low-sensitivity or single-marker platforms may be displaced by high-sensitivity, multi-marker, automated, and connected platforms. Regional differences in policy, regulation, and clinical adoption may also influence market growth. A company's R&D capabilities, clinical support system, marketing strategies, and service network directly determine its competitive position. Technological innovation and comprehensive service systems remain critical to overcoming market barriers and driving sustainable industry development.
This report is a detailed and comprehensive analysis for global Cardiac Biomarker POCT Diagnostic Device market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Cardiac Biomarker POCT Diagnostic Device market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Cardiac Biomarker POCT Diagnostic Device market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Cardiac Biomarker POCT Diagnostic Device market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Cardiac Biomarker POCT Diagnostic Device market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Cardiac Biomarker POCT Diagnostic Device market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
The Cardiac Biomarker POCT Diagnostic Device is designed for emergency departments, chest pain centers, intensive care units, cardiology outpatient clinics, primary care, and pre-hospital emergency use. It utilizes fluorescence immunoassay, chemiluminescence, and microfluidic technologies to measure cardiac injury markers including cTnI, hs-cTnI, cTnT, CK-MB, and myoglobin, as well as heart failure biomarkers BNP and NT-proBNP. Upstream materials include highly specific monoclonal antibodies, fluorescent labels, microfluidic chips, and dedicated consumables. The main customers are hospitals, emergency and chest pain centers, ICUs, cardiology clinics, primary care facilities, and pre-hospital emergency services worldwide. In 2025, global production capacity is approximately 26,500 units, with actual sales around 21,380 units, an average ex-factory price of 11,200 USD per unit, and a gross margin range of 38%?50%.
The global market for cardiac biomarker POCT diagnostic devices exhibits a multi-layered competitive structure, with high-end companies in North America, Europe, and Japan coexisting with mid-tier manufacturers in China and South Korea. Emergency departments, chest pain centers, and ICUs remain core application areas. Platforms have evolved from single-marker testing to high-sensitivity troponin, multi-marker panels, microfluidic, and fluorescence immunoassay technologies, creating a complete ecosystem of analyzers and reagent consumables. Manufacturers establish recurring revenue and customer stickiness through consumable binding, hospital data integration, and workflow coordination. Chinese and Korean companies expand market share through cost control, rapid product iteration, and export channels, while Western and Japanese leaders maintain technological and brand advantages in high-end hospital settings, also pushing the integration of high-sensitivity assays and connected data systems.
Future trends indicate continuous growth in platform-based, multi-marker testing and high-sensitivity troponin penetration. Next-generation devices will increasingly feature microfluidic chips, dry fluorescence assays, automated operation systems, portability, and networked functionality. Information integration and data management capabilities are becoming critical for platform competitiveness, driving optimization of emergency workflows, remote monitoring, and differentiated clinical decision support. Regionally, Chinese and Korean firms are rapidly expanding mid-tier and export markets, while Western and Japanese companies maintain leadership in high-end hospitals, forming a globally multi-tiered, regionally complementary market. Clinical validation and standardization of new technologies will further enhance device reliability and physician acceptance, supporting sustained market growth.
Market growth is primarily driven by strong clinical demand for rapid and high-precision testing. High-sensitivity assays and multi-marker panels optimize acute myocardial infarction triage, heart failure evaluation, and critical patient monitoring. Technological iteration and new product development not only enhance platform capabilities but also provide opportunities for market share expansion and improved gross margins. Downstream customers include hospitals, emergency and chest pain centers, ICUs, cardiology outpatient clinics, primary care facilities, and pre-hospital emergency services. Companies achieve sustainable revenue through device-consumable integration, client management, and service upgrades, establishing long-term competitive barriers in clinical protocols and hospital workflows.
Obstacles include stringent regulatory and clinical validation requirements, hospital procurement pacing, and constraints from reimbursement and payment systems. Low-sensitivity or single-marker platforms may be displaced by high-sensitivity, multi-marker, automated, and connected platforms. Regional differences in policy, regulation, and clinical adoption may also influence market growth. A company's R&D capabilities, clinical support system, marketing strategies, and service network directly determine its competitive position. Technological innovation and comprehensive service systems remain critical to overcoming market barriers and driving sustainable industry development.
This report is a detailed and comprehensive analysis for global Cardiac Biomarker POCT Diagnostic Device market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Cardiac Biomarker POCT Diagnostic Device market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Cardiac Biomarker POCT Diagnostic Device market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Cardiac Biomarker POCT Diagnostic Device market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Cardiac Biomarker POCT Diagnostic Device market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To assess the growth potential for Cardiac Biomarker POCT Diagnostic Device
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Cardiac Biomarker POCT Diagnostic Device market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Fluorescence Immunoassay
- Chemiluminescence Immunoassay
- Other
- Handheld
- Benchtop
- Other
- Troponin-focused
- Natriuretic Peptide-focused
- Other
- Hospital
- Clinic
- Others
- Roche
- Abbott Laboratories
- QuidelOrtho Corporation
- Radiometer Medical
- Siemens Healthineers
- PHC Holdings
- Guangzhou Wondfo Biotech
- Getein Biotech
- Boditech Med
- SD BIOSENSOR
- Lepu Medical Technology
- Humasis
- NanoEntek
- Xiamen Biotime Biotechnology
- Nanjing Lansion Biotechnology
- Shenzhen Micropoint Biotechnologies
- Shijiazhuang Hipro Biotechnology
- AEHEALTH
- Guangzhou KOFA Biotechnology
- Response Biomedical
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
- Chapter 1, to describe Cardiac Biomarker POCT Diagnostic Device product scope, market overview, market estimation caveats and base year.
- Chapter 2, to profile the top manufacturers of Cardiac Biomarker POCT Diagnostic Device, with price, sales quantity, revenue, and global market share of Cardiac Biomarker POCT Diagnostic Device from 2021 to 2026.
- Chapter 3, the Cardiac Biomarker POCT Diagnostic Device competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
- Chapter 4, the Cardiac Biomarker POCT Diagnostic Device breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
- Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
- Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Cardiac Biomarker POCT Diagnostic Device market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
- Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
- Chapter 13, the key raw materials and key suppliers, and industry chain of Cardiac Biomarker POCT Diagnostic Device.
- Chapter 14 and 15, to describe Cardiac Biomarker POCT Diagnostic Device sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Cardiac Biomarker POCT Diagnostic Device Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 Fluorescence Immunoassay
1.3.3 Chemiluminescence Immunoassay
1.3.4 Other
1.4 Market Analysis by Form
1.4.1 Overview: Global Cardiac Biomarker POCT Diagnostic Device Consumption Value by Form: 2021 Versus 2025 Versus 2032
1.4.2 Handheld
1.4.3 Benchtop
1.4.4 Other
1.5 Market Analysis by Cardiac Biomarker
1.5.1 Overview: Global Cardiac Biomarker POCT Diagnostic Device Consumption Value by Cardiac Biomarker: 2021 Versus 2025 Versus 2032
1.5.2 Troponin-focused
1.5.3 Natriuretic Peptide-focused
1.5.4 Other
1.6 Market Analysis by Application
1.6.1 Overview: Global Cardiac Biomarker POCT Diagnostic Device Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.6.2 Hospital
1.6.3 Clinic
1.6.4 Others
1.7 Global Cardiac Biomarker POCT Diagnostic Device Market Size & Forecast
1.7.1 Global Cardiac Biomarker POCT Diagnostic Device Consumption Value (2021 & 2025 & 2032)
1.7.2 Global Cardiac Biomarker POCT Diagnostic Device Sales Quantity (2021-2032)
1.7.3 Global Cardiac Biomarker POCT Diagnostic Device Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Cardiac Biomarker POCT Diagnostic Device Product and Services
2.1.4 Roche Cardiac Biomarker POCT Diagnostic Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Roche Recent Developments/Updates
2.2 Abbott Laboratories
2.2.1 Abbott Laboratories Details
2.2.2 Abbott Laboratories Major Business
2.2.3 Abbott Laboratories Cardiac Biomarker POCT Diagnostic Device Product and Services
2.2.4 Abbott Laboratories Cardiac Biomarker POCT Diagnostic Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Abbott Laboratories Recent Developments/Updates
2.3 QuidelOrtho Corporation
2.3.1 QuidelOrtho Corporation Details
2.3.2 QuidelOrtho Corporation Major Business
2.3.3 QuidelOrtho Corporation Cardiac Biomarker POCT Diagnostic Device Product and Services
2.3.4 QuidelOrtho Corporation Cardiac Biomarker POCT Diagnostic Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 QuidelOrtho Corporation Recent Developments/Updates
2.4 Radiometer Medical
2.4.1 Radiometer Medical Details
2.4.2 Radiometer Medical Major Business
2.4.3 Radiometer Medical Cardiac Biomarker POCT Diagnostic Device Product and Services
2.4.4 Radiometer Medical Cardiac Biomarker POCT Diagnostic Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Radiometer Medical Recent Developments/Updates
2.5 Siemens Healthineers
2.5.1 Siemens Healthineers Details
2.5.2 Siemens Healthineers Major Business
2.5.3 Siemens Healthineers Cardiac Biomarker POCT Diagnostic Device Product and Services
2.5.4 Siemens Healthineers Cardiac Biomarker POCT Diagnostic Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Siemens Healthineers Recent Developments/Updates
2.6 PHC Holdings
2.6.1 PHC Holdings Details
2.6.2 PHC Holdings Major Business
2.6.3 PHC Holdings Cardiac Biomarker POCT Diagnostic Device Product and Services
2.6.4 PHC Holdings Cardiac Biomarker POCT Diagnostic Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 PHC Holdings Recent Developments/Updates
2.7 Guangzhou Wondfo Biotech
2.7.1 Guangzhou Wondfo Biotech Details
2.7.2 Guangzhou Wondfo Biotech Major Business
2.7.3 Guangzhou Wondfo Biotech Cardiac Biomarker POCT Diagnostic Device Product and Services
2.7.4 Guangzhou Wondfo Biotech Cardiac Biomarker POCT Diagnostic Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Guangzhou Wondfo Biotech Recent Developments/Updates
2.8 Getein Biotech
2.8.1 Getein Biotech Details
2.8.2 Getein Biotech Major Business
2.8.3 Getein Biotech Cardiac Biomarker POCT Diagnostic Device Product and Services
2.8.4 Getein Biotech Cardiac Biomarker POCT Diagnostic Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Getein Biotech Recent Developments/Updates
2.9 Boditech Med
2.9.1 Boditech Med Details
2.9.2 Boditech Med Major Business
2.9.3 Boditech Med Cardiac Biomarker POCT Diagnostic Device Product and Services
2.9.4 Boditech Med Cardiac Biomarker POCT Diagnostic Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Boditech Med Recent Developments/Updates
2.10 SD BIOSENSOR
2.10.1 SD BIOSENSOR Details
2.10.2 SD BIOSENSOR Major Business
2.10.3 SD BIOSENSOR Cardiac Biomarker POCT Diagnostic Device Product and Services
2.10.4 SD BIOSENSOR Cardiac Biomarker POCT Diagnostic Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 SD BIOSENSOR Recent Developments/Updates
2.11 Lepu Medical Technology
2.11.1 Lepu Medical Technology Details
2.11.2 Lepu Medical Technology Major Business
2.11.3 Lepu Medical Technology Cardiac Biomarker POCT Diagnostic Device Product and Services
2.11.4 Lepu Medical Technology Cardiac Biomarker POCT Diagnostic Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Lepu Medical Technology Recent Developments/Updates
2.12 Humasis
2.12.1 Humasis Details
2.12.2 Humasis Major Business
2.12.3 Humasis Cardiac Biomarker POCT Diagnostic Device Product and Services
2.12.4 Humasis Cardiac Biomarker POCT Diagnostic Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Humasis Recent Developments/Updates
2.13 NanoEntek
2.13.1 NanoEntek Details
2.13.2 NanoEntek Major Business
2.13.3 NanoEntek Cardiac Biomarker POCT Diagnostic Device Product and Services
2.13.4 NanoEntek Cardiac Biomarker POCT Diagnostic Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 NanoEntek Recent Developments/Updates
2.14 Xiamen Biotime Biotechnology
2.14.1 Xiamen Biotime Biotechnology Details
2.14.2 Xiamen Biotime Biotechnology Major Business
2.14.3 Xiamen Biotime Biotechnology Cardiac Biomarker POCT Diagnostic Device Product and Services
2.14.4 Xiamen Biotime Biotechnology Cardiac Biomarker POCT Diagnostic Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Xiamen Biotime Biotechnology Recent Developments/Updates
2.15 Nanjing Lansion Biotechnology
2.15.1 Nanjing Lansion Biotechnology Details
2.15.2 Nanjing Lansion Biotechnology Major Business
2.15.3 Nanjing Lansion Biotechnology Cardiac Biomarker POCT Diagnostic Device Product and Services
2.15.4 Nanjing Lansion Biotechnology Cardiac Biomarker POCT Diagnostic Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Nanjing Lansion Biotechnology Recent Developments/Updates
2.16 Shenzhen Micropoint Biotechnologies
2.16.1 Shenzhen Micropoint Biotechnologies Details
2.16.2 Shenzhen Micropoint Biotechnologies Major Business
2.16.3 Shenzhen Micropoint Biotechnologies Cardiac Biomarker POCT Diagnostic Device Product and Services
2.16.4 Shenzhen Micropoint Biotechnologies Cardiac Biomarker POCT Diagnostic Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 Shenzhen Micropoint Biotechnologies Recent Developments/Updates
2.17 Shijiazhuang Hipro Biotechnology
2.17.1 Shijiazhuang Hipro Biotechnology Details
2.17.2 Shijiazhuang Hipro Biotechnology Major Business
2.17.3 Shijiazhuang Hipro Biotechnology Cardiac Biomarker POCT Diagnostic Device Product and Services
2.17.4 Shijiazhuang Hipro Biotechnology Cardiac Biomarker POCT Diagnostic Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 Shijiazhuang Hipro Biotechnology Recent Developments/Updates
2.18 AEHEALTH
2.18.1 AEHEALTH Details
2.18.2 AEHEALTH Major Business
2.18.3 AEHEALTH Cardiac Biomarker POCT Diagnostic Device Product and Services
2.18.4 AEHEALTH Cardiac Biomarker POCT Diagnostic Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.18.5 AEHEALTH Recent Developments/Updates
2.19 Guangzhou KOFA Biotechnology
2.19.1 Guangzhou KOFA Biotechnology Details
2.19.2 Guangzhou KOFA Biotechnology Major Business
2.19.3 Guangzhou KOFA Biotechnology Cardiac Biomarker POCT Diagnostic Device Product and Services
2.19.4 Guangzhou KOFA Biotechnology Cardiac Biomarker POCT Diagnostic Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.19.5 Guangzhou KOFA Biotechnology Recent Developments/Updates
2.20 Response Biomedical
2.20.1 Response Biomedical Details
2.20.2 Response Biomedical Major Business
2.20.3 Response Biomedical Cardiac Biomarker POCT Diagnostic Device Product and Services
2.20.4 Response Biomedical Cardiac Biomarker POCT Diagnostic Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.20.5 Response Biomedical Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: CARDIAC BIOMARKER POCT DIAGNOSTIC DEVICE BY MANUFACTURER
3.1 Global Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Manufacturer (2021-2026)
3.2 Global Cardiac Biomarker POCT Diagnostic Device Revenue by Manufacturer (2021-2026)
3.3 Global Cardiac Biomarker POCT Diagnostic Device Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Cardiac Biomarker POCT Diagnostic Device by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Cardiac Biomarker POCT Diagnostic Device Manufacturer Market Share in 2025
3.4.3 Top 6 Cardiac Biomarker POCT Diagnostic Device Manufacturer Market Share in 2025
3.5 Cardiac Biomarker POCT Diagnostic Device Market: Overall Company Footprint Analysis
3.5.1 Cardiac Biomarker POCT Diagnostic Device Market: Region Footprint
3.5.2 Cardiac Biomarker POCT Diagnostic Device Market: Company Product Type Footprint
3.5.3 Cardiac Biomarker POCT Diagnostic Device Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Cardiac Biomarker POCT Diagnostic Device Market Size by Region
4.1.1 Global Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Region (2021-2032)
4.1.2 Global Cardiac Biomarker POCT Diagnostic Device Consumption Value by Region (2021-2032)
4.1.3 Global Cardiac Biomarker POCT Diagnostic Device Average Price by Region (2021-2032)
4.2 North America Cardiac Biomarker POCT Diagnostic Device Consumption Value (2021-2032)
4.3 Europe Cardiac Biomarker POCT Diagnostic Device Consumption Value (2021-2032)
4.4 Asia-Pacific Cardiac Biomarker POCT Diagnostic Device Consumption Value (2021-2032)
4.5 South America Cardiac Biomarker POCT Diagnostic Device Consumption Value (2021-2032)
4.6 Middle East & Africa Cardiac Biomarker POCT Diagnostic Device Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Type (2021-2032)
5.2 Global Cardiac Biomarker POCT Diagnostic Device Consumption Value by Type (2021-2032)
5.3 Global Cardiac Biomarker POCT Diagnostic Device Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Application (2021-2032)
6.2 Global Cardiac Biomarker POCT Diagnostic Device Consumption Value by Application (2021-2032)
6.3 Global Cardiac Biomarker POCT Diagnostic Device Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Type (2021-2032)
7.2 North America Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Application (2021-2032)
7.3 North America Cardiac Biomarker POCT Diagnostic Device Market Size by Country
7.3.1 North America Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Country (2021-2032)
7.3.2 North America Cardiac Biomarker POCT Diagnostic Device Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Type (2021-2032)
8.2 Europe Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Application (2021-2032)
8.3 Europe Cardiac Biomarker POCT Diagnostic Device Market Size by Country
8.3.1 Europe Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Country (2021-2032)
8.3.2 Europe Cardiac Biomarker POCT Diagnostic Device Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Cardiac Biomarker POCT Diagnostic Device Market Size by Region
9.3.1 Asia-Pacific Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Cardiac Biomarker POCT Diagnostic Device Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Type (2021-2032)
10.2 South America Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Application (2021-2032)
10.3 South America Cardiac Biomarker POCT Diagnostic Device Market Size by Country
10.3.1 South America Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Country (2021-2032)
10.3.2 South America Cardiac Biomarker POCT Diagnostic Device Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Cardiac Biomarker POCT Diagnostic Device Market Size by Country
11.3.1 Middle East & Africa Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Cardiac Biomarker POCT Diagnostic Device Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Cardiac Biomarker POCT Diagnostic Device Market Drivers
12.2 Cardiac Biomarker POCT Diagnostic Device Market Restraints
12.3 Cardiac Biomarker POCT Diagnostic Device Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Cardiac Biomarker POCT Diagnostic Device and Key Manufacturers
13.2 Manufacturing Costs Percentage of Cardiac Biomarker POCT Diagnostic Device
13.3 Cardiac Biomarker POCT Diagnostic Device Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Cardiac Biomarker POCT Diagnostic Device Typical Distributors
14.3 Cardiac Biomarker POCT Diagnostic Device Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Cardiac Biomarker POCT Diagnostic Device Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 Fluorescence Immunoassay
1.3.3 Chemiluminescence Immunoassay
1.3.4 Other
1.4 Market Analysis by Form
1.4.1 Overview: Global Cardiac Biomarker POCT Diagnostic Device Consumption Value by Form: 2021 Versus 2025 Versus 2032
1.4.2 Handheld
1.4.3 Benchtop
1.4.4 Other
1.5 Market Analysis by Cardiac Biomarker
1.5.1 Overview: Global Cardiac Biomarker POCT Diagnostic Device Consumption Value by Cardiac Biomarker: 2021 Versus 2025 Versus 2032
1.5.2 Troponin-focused
1.5.3 Natriuretic Peptide-focused
1.5.4 Other
1.6 Market Analysis by Application
1.6.1 Overview: Global Cardiac Biomarker POCT Diagnostic Device Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.6.2 Hospital
1.6.3 Clinic
1.6.4 Others
1.7 Global Cardiac Biomarker POCT Diagnostic Device Market Size & Forecast
1.7.1 Global Cardiac Biomarker POCT Diagnostic Device Consumption Value (2021 & 2025 & 2032)
1.7.2 Global Cardiac Biomarker POCT Diagnostic Device Sales Quantity (2021-2032)
1.7.3 Global Cardiac Biomarker POCT Diagnostic Device Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Cardiac Biomarker POCT Diagnostic Device Product and Services
2.1.4 Roche Cardiac Biomarker POCT Diagnostic Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Roche Recent Developments/Updates
2.2 Abbott Laboratories
2.2.1 Abbott Laboratories Details
2.2.2 Abbott Laboratories Major Business
2.2.3 Abbott Laboratories Cardiac Biomarker POCT Diagnostic Device Product and Services
2.2.4 Abbott Laboratories Cardiac Biomarker POCT Diagnostic Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Abbott Laboratories Recent Developments/Updates
2.3 QuidelOrtho Corporation
2.3.1 QuidelOrtho Corporation Details
2.3.2 QuidelOrtho Corporation Major Business
2.3.3 QuidelOrtho Corporation Cardiac Biomarker POCT Diagnostic Device Product and Services
2.3.4 QuidelOrtho Corporation Cardiac Biomarker POCT Diagnostic Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 QuidelOrtho Corporation Recent Developments/Updates
2.4 Radiometer Medical
2.4.1 Radiometer Medical Details
2.4.2 Radiometer Medical Major Business
2.4.3 Radiometer Medical Cardiac Biomarker POCT Diagnostic Device Product and Services
2.4.4 Radiometer Medical Cardiac Biomarker POCT Diagnostic Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Radiometer Medical Recent Developments/Updates
2.5 Siemens Healthineers
2.5.1 Siemens Healthineers Details
2.5.2 Siemens Healthineers Major Business
2.5.3 Siemens Healthineers Cardiac Biomarker POCT Diagnostic Device Product and Services
2.5.4 Siemens Healthineers Cardiac Biomarker POCT Diagnostic Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Siemens Healthineers Recent Developments/Updates
2.6 PHC Holdings
2.6.1 PHC Holdings Details
2.6.2 PHC Holdings Major Business
2.6.3 PHC Holdings Cardiac Biomarker POCT Diagnostic Device Product and Services
2.6.4 PHC Holdings Cardiac Biomarker POCT Diagnostic Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 PHC Holdings Recent Developments/Updates
2.7 Guangzhou Wondfo Biotech
2.7.1 Guangzhou Wondfo Biotech Details
2.7.2 Guangzhou Wondfo Biotech Major Business
2.7.3 Guangzhou Wondfo Biotech Cardiac Biomarker POCT Diagnostic Device Product and Services
2.7.4 Guangzhou Wondfo Biotech Cardiac Biomarker POCT Diagnostic Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Guangzhou Wondfo Biotech Recent Developments/Updates
2.8 Getein Biotech
2.8.1 Getein Biotech Details
2.8.2 Getein Biotech Major Business
2.8.3 Getein Biotech Cardiac Biomarker POCT Diagnostic Device Product and Services
2.8.4 Getein Biotech Cardiac Biomarker POCT Diagnostic Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Getein Biotech Recent Developments/Updates
2.9 Boditech Med
2.9.1 Boditech Med Details
2.9.2 Boditech Med Major Business
2.9.3 Boditech Med Cardiac Biomarker POCT Diagnostic Device Product and Services
2.9.4 Boditech Med Cardiac Biomarker POCT Diagnostic Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Boditech Med Recent Developments/Updates
2.10 SD BIOSENSOR
2.10.1 SD BIOSENSOR Details
2.10.2 SD BIOSENSOR Major Business
2.10.3 SD BIOSENSOR Cardiac Biomarker POCT Diagnostic Device Product and Services
2.10.4 SD BIOSENSOR Cardiac Biomarker POCT Diagnostic Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 SD BIOSENSOR Recent Developments/Updates
2.11 Lepu Medical Technology
2.11.1 Lepu Medical Technology Details
2.11.2 Lepu Medical Technology Major Business
2.11.3 Lepu Medical Technology Cardiac Biomarker POCT Diagnostic Device Product and Services
2.11.4 Lepu Medical Technology Cardiac Biomarker POCT Diagnostic Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Lepu Medical Technology Recent Developments/Updates
2.12 Humasis
2.12.1 Humasis Details
2.12.2 Humasis Major Business
2.12.3 Humasis Cardiac Biomarker POCT Diagnostic Device Product and Services
2.12.4 Humasis Cardiac Biomarker POCT Diagnostic Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Humasis Recent Developments/Updates
2.13 NanoEntek
2.13.1 NanoEntek Details
2.13.2 NanoEntek Major Business
2.13.3 NanoEntek Cardiac Biomarker POCT Diagnostic Device Product and Services
2.13.4 NanoEntek Cardiac Biomarker POCT Diagnostic Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 NanoEntek Recent Developments/Updates
2.14 Xiamen Biotime Biotechnology
2.14.1 Xiamen Biotime Biotechnology Details
2.14.2 Xiamen Biotime Biotechnology Major Business
2.14.3 Xiamen Biotime Biotechnology Cardiac Biomarker POCT Diagnostic Device Product and Services
2.14.4 Xiamen Biotime Biotechnology Cardiac Biomarker POCT Diagnostic Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Xiamen Biotime Biotechnology Recent Developments/Updates
2.15 Nanjing Lansion Biotechnology
2.15.1 Nanjing Lansion Biotechnology Details
2.15.2 Nanjing Lansion Biotechnology Major Business
2.15.3 Nanjing Lansion Biotechnology Cardiac Biomarker POCT Diagnostic Device Product and Services
2.15.4 Nanjing Lansion Biotechnology Cardiac Biomarker POCT Diagnostic Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Nanjing Lansion Biotechnology Recent Developments/Updates
2.16 Shenzhen Micropoint Biotechnologies
2.16.1 Shenzhen Micropoint Biotechnologies Details
2.16.2 Shenzhen Micropoint Biotechnologies Major Business
2.16.3 Shenzhen Micropoint Biotechnologies Cardiac Biomarker POCT Diagnostic Device Product and Services
2.16.4 Shenzhen Micropoint Biotechnologies Cardiac Biomarker POCT Diagnostic Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 Shenzhen Micropoint Biotechnologies Recent Developments/Updates
2.17 Shijiazhuang Hipro Biotechnology
2.17.1 Shijiazhuang Hipro Biotechnology Details
2.17.2 Shijiazhuang Hipro Biotechnology Major Business
2.17.3 Shijiazhuang Hipro Biotechnology Cardiac Biomarker POCT Diagnostic Device Product and Services
2.17.4 Shijiazhuang Hipro Biotechnology Cardiac Biomarker POCT Diagnostic Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 Shijiazhuang Hipro Biotechnology Recent Developments/Updates
2.18 AEHEALTH
2.18.1 AEHEALTH Details
2.18.2 AEHEALTH Major Business
2.18.3 AEHEALTH Cardiac Biomarker POCT Diagnostic Device Product and Services
2.18.4 AEHEALTH Cardiac Biomarker POCT Diagnostic Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.18.5 AEHEALTH Recent Developments/Updates
2.19 Guangzhou KOFA Biotechnology
2.19.1 Guangzhou KOFA Biotechnology Details
2.19.2 Guangzhou KOFA Biotechnology Major Business
2.19.3 Guangzhou KOFA Biotechnology Cardiac Biomarker POCT Diagnostic Device Product and Services
2.19.4 Guangzhou KOFA Biotechnology Cardiac Biomarker POCT Diagnostic Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.19.5 Guangzhou KOFA Biotechnology Recent Developments/Updates
2.20 Response Biomedical
2.20.1 Response Biomedical Details
2.20.2 Response Biomedical Major Business
2.20.3 Response Biomedical Cardiac Biomarker POCT Diagnostic Device Product and Services
2.20.4 Response Biomedical Cardiac Biomarker POCT Diagnostic Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.20.5 Response Biomedical Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: CARDIAC BIOMARKER POCT DIAGNOSTIC DEVICE BY MANUFACTURER
3.1 Global Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Manufacturer (2021-2026)
3.2 Global Cardiac Biomarker POCT Diagnostic Device Revenue by Manufacturer (2021-2026)
3.3 Global Cardiac Biomarker POCT Diagnostic Device Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Cardiac Biomarker POCT Diagnostic Device by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Cardiac Biomarker POCT Diagnostic Device Manufacturer Market Share in 2025
3.4.3 Top 6 Cardiac Biomarker POCT Diagnostic Device Manufacturer Market Share in 2025
3.5 Cardiac Biomarker POCT Diagnostic Device Market: Overall Company Footprint Analysis
3.5.1 Cardiac Biomarker POCT Diagnostic Device Market: Region Footprint
3.5.2 Cardiac Biomarker POCT Diagnostic Device Market: Company Product Type Footprint
3.5.3 Cardiac Biomarker POCT Diagnostic Device Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Cardiac Biomarker POCT Diagnostic Device Market Size by Region
4.1.1 Global Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Region (2021-2032)
4.1.2 Global Cardiac Biomarker POCT Diagnostic Device Consumption Value by Region (2021-2032)
4.1.3 Global Cardiac Biomarker POCT Diagnostic Device Average Price by Region (2021-2032)
4.2 North America Cardiac Biomarker POCT Diagnostic Device Consumption Value (2021-2032)
4.3 Europe Cardiac Biomarker POCT Diagnostic Device Consumption Value (2021-2032)
4.4 Asia-Pacific Cardiac Biomarker POCT Diagnostic Device Consumption Value (2021-2032)
4.5 South America Cardiac Biomarker POCT Diagnostic Device Consumption Value (2021-2032)
4.6 Middle East & Africa Cardiac Biomarker POCT Diagnostic Device Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Type (2021-2032)
5.2 Global Cardiac Biomarker POCT Diagnostic Device Consumption Value by Type (2021-2032)
5.3 Global Cardiac Biomarker POCT Diagnostic Device Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Application (2021-2032)
6.2 Global Cardiac Biomarker POCT Diagnostic Device Consumption Value by Application (2021-2032)
6.3 Global Cardiac Biomarker POCT Diagnostic Device Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Type (2021-2032)
7.2 North America Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Application (2021-2032)
7.3 North America Cardiac Biomarker POCT Diagnostic Device Market Size by Country
7.3.1 North America Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Country (2021-2032)
7.3.2 North America Cardiac Biomarker POCT Diagnostic Device Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Type (2021-2032)
8.2 Europe Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Application (2021-2032)
8.3 Europe Cardiac Biomarker POCT Diagnostic Device Market Size by Country
8.3.1 Europe Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Country (2021-2032)
8.3.2 Europe Cardiac Biomarker POCT Diagnostic Device Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Cardiac Biomarker POCT Diagnostic Device Market Size by Region
9.3.1 Asia-Pacific Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Cardiac Biomarker POCT Diagnostic Device Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Type (2021-2032)
10.2 South America Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Application (2021-2032)
10.3 South America Cardiac Biomarker POCT Diagnostic Device Market Size by Country
10.3.1 South America Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Country (2021-2032)
10.3.2 South America Cardiac Biomarker POCT Diagnostic Device Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Cardiac Biomarker POCT Diagnostic Device Market Size by Country
11.3.1 Middle East & Africa Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Cardiac Biomarker POCT Diagnostic Device Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Cardiac Biomarker POCT Diagnostic Device Market Drivers
12.2 Cardiac Biomarker POCT Diagnostic Device Market Restraints
12.3 Cardiac Biomarker POCT Diagnostic Device Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Cardiac Biomarker POCT Diagnostic Device and Key Manufacturers
13.2 Manufacturing Costs Percentage of Cardiac Biomarker POCT Diagnostic Device
13.3 Cardiac Biomarker POCT Diagnostic Device Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Cardiac Biomarker POCT Diagnostic Device Typical Distributors
14.3 Cardiac Biomarker POCT Diagnostic Device Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Cardiac Biomarker POCT Diagnostic Device Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Cardiac Biomarker POCT Diagnostic Device Consumption Value by Form, (USD Million), 2021 & 2025 & 2032
Table 3. Global Cardiac Biomarker POCT Diagnostic Device Consumption Value by Cardiac Biomarker, (USD Million), 2021 & 2025 & 2032
Table 4. Global Cardiac Biomarker POCT Diagnostic Device Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Roche Basic Information, Manufacturing Base and Competitors
Table 6. Roche Major Business
Table 7. Roche Cardiac Biomarker POCT Diagnostic Device Product and Services
Table 8. Roche Cardiac Biomarker POCT Diagnostic Device Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. Roche Recent Developments/Updates
Table 10. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 11. Abbott Laboratories Major Business
Table 12. Abbott Laboratories Cardiac Biomarker POCT Diagnostic Device Product and Services
Table 13. Abbott Laboratories Cardiac Biomarker POCT Diagnostic Device Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. Abbott Laboratories Recent Developments/Updates
Table 15. QuidelOrtho Corporation Basic Information, Manufacturing Base and Competitors
Table 16. QuidelOrtho Corporation Major Business
Table 17. QuidelOrtho Corporation Cardiac Biomarker POCT Diagnostic Device Product and Services
Table 18. QuidelOrtho Corporation Cardiac Biomarker POCT Diagnostic Device Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 19. QuidelOrtho Corporation Recent Developments/Updates
Table 20. Radiometer Medical Basic Information, Manufacturing Base and Competitors
Table 21. Radiometer Medical Major Business
Table 22. Radiometer Medical Cardiac Biomarker POCT Diagnostic Device Product and Services
Table 23. Radiometer Medical Cardiac Biomarker POCT Diagnostic Device Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 24. Radiometer Medical Recent Developments/Updates
Table 25. Siemens Healthineers Basic Information, Manufacturing Base and Competitors
Table 26. Siemens Healthineers Major Business
Table 27. Siemens Healthineers Cardiac Biomarker POCT Diagnostic Device Product and Services
Table 28. Siemens Healthineers Cardiac Biomarker POCT Diagnostic Device Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 29. Siemens Healthineers Recent Developments/Updates
Table 30. PHC Holdings Basic Information, Manufacturing Base and Competitors
Table 31. PHC Holdings Major Business
Table 32. PHC Holdings Cardiac Biomarker POCT Diagnostic Device Product and Services
Table 33. PHC Holdings Cardiac Biomarker POCT Diagnostic Device Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 34. PHC Holdings Recent Developments/Updates
Table 35. Guangzhou Wondfo Biotech Basic Information, Manufacturing Base and Competitors
Table 36. Guangzhou Wondfo Biotech Major Business
Table 37. Guangzhou Wondfo Biotech Cardiac Biomarker POCT Diagnostic Device Product and Services
Table 38. Guangzhou Wondfo Biotech Cardiac Biomarker POCT Diagnostic Device Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 39. Guangzhou Wondfo Biotech Recent Developments/Updates
Table 40. Getein Biotech Basic Information, Manufacturing Base and Competitors
Table 41. Getein Biotech Major Business
Table 42. Getein Biotech Cardiac Biomarker POCT Diagnostic Device Product and Services
Table 43. Getein Biotech Cardiac Biomarker POCT Diagnostic Device Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 44. Getein Biotech Recent Developments/Updates
Table 45. Boditech Med Basic Information, Manufacturing Base and Competitors
Table 46. Boditech Med Major Business
Table 47. Boditech Med Cardiac Biomarker POCT Diagnostic Device Product and Services
Table 48. Boditech Med Cardiac Biomarker POCT Diagnostic Device Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 49. Boditech Med Recent Developments/Updates
Table 50. SD BIOSENSOR Basic Information, Manufacturing Base and Competitors
Table 51. SD BIOSENSOR Major Business
Table 52. SD BIOSENSOR Cardiac Biomarker POCT Diagnostic Device Product and Services
Table 53. SD BIOSENSOR Cardiac Biomarker POCT Diagnostic Device Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 54. SD BIOSENSOR Recent Developments/Updates
Table 55. Lepu Medical Technology Basic Information, Manufacturing Base and Competitors
Table 56. Lepu Medical Technology Major Business
Table 57. Lepu Medical Technology Cardiac Biomarker POCT Diagnostic Device Product and Services
Table 58. Lepu Medical Technology Cardiac Biomarker POCT Diagnostic Device Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 59. Lepu Medical Technology Recent Developments/Updates
Table 60. Humasis Basic Information, Manufacturing Base and Competitors
Table 61. Humasis Major Business
Table 62. Humasis Cardiac Biomarker POCT Diagnostic Device Product and Services
Table 63. Humasis Cardiac Biomarker POCT Diagnostic Device Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 64. Humasis Recent Developments/Updates
Table 65. NanoEntek Basic Information, Manufacturing Base and Competitors
Table 66. NanoEntek Major Business
Table 67. NanoEntek Cardiac Biomarker POCT Diagnostic Device Product and Services
Table 68. NanoEntek Cardiac Biomarker POCT Diagnostic Device Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 69. NanoEntek Recent Developments/Updates
Table 70. Xiamen Biotime Biotechnology Basic Information, Manufacturing Base and Competitors
Table 71. Xiamen Biotime Biotechnology Major Business
Table 72. Xiamen Biotime Biotechnology Cardiac Biomarker POCT Diagnostic Device Product and Services
Table 73. Xiamen Biotime Biotechnology Cardiac Biomarker POCT Diagnostic Device Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 74. Xiamen Biotime Biotechnology Recent Developments/Updates
Table 75. Nanjing Lansion Biotechnology Basic Information, Manufacturing Base and Competitors
Table 76. Nanjing Lansion Biotechnology Major Business
Table 77. Nanjing Lansion Biotechnology Cardiac Biomarker POCT Diagnostic Device Product and Services
Table 78. Nanjing Lansion Biotechnology Cardiac Biomarker POCT Diagnostic Device Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Nanjing Lansion Biotechnology Recent Developments/Updates
Table 80. Shenzhen Micropoint Biotechnologies Basic Information, Manufacturing Base and Competitors
Table 81. Shenzhen Micropoint Biotechnologies Major Business
Table 82. Shenzhen Micropoint Biotechnologies Cardiac Biomarker POCT Diagnostic Device Product and Services
Table 83. Shenzhen Micropoint Biotechnologies Cardiac Biomarker POCT Diagnostic Device Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 84. Shenzhen Micropoint Biotechnologies Recent Developments/Updates
Table 85. Shijiazhuang Hipro Biotechnology Basic Information, Manufacturing Base and Competitors
Table 86. Shijiazhuang Hipro Biotechnology Major Business
Table 87. Shijiazhuang Hipro Biotechnology Cardiac Biomarker POCT Diagnostic Device Product and Services
Table 88. Shijiazhuang Hipro Biotechnology Cardiac Biomarker POCT Diagnostic Device Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 89. Shijiazhuang Hipro Biotechnology Recent Developments/Updates
Table 90. AEHEALTH Basic Information, Manufacturing Base and Competitors
Table 91. AEHEALTH Major Business
Table 92. AEHEALTH Cardiac Biomarker POCT Diagnostic Device Product and Services
Table 93. AEHEALTH Cardiac Biomarker POCT Diagnostic Device Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 94. AEHEALTH Recent Developments/Updates
Table 95. Guangzhou KOFA Biotechnology Basic Information, Manufacturing Base and Competitors
Table 96. Guangzhou KOFA Biotechnology Major Business
Table 97. Guangzhou KOFA Biotechnology Cardiac Biomarker POCT Diagnostic Device Product and Services
Table 98. Guangzhou KOFA Biotechnology Cardiac Biomarker POCT Diagnostic Device Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 99. Guangzhou KOFA Biotechnology Recent Developments/Updates
Table 100. Response Biomedical Basic Information, Manufacturing Base and Competitors
Table 101. Response Biomedical Major Business
Table 102. Response Biomedical Cardiac Biomarker POCT Diagnostic Device Product and Services
Table 103. Response Biomedical Cardiac Biomarker POCT Diagnostic Device Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 104. Response Biomedical Recent Developments/Updates
Table 105. Global Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Manufacturer (2021-2026) & (Units)
Table 106. Global Cardiac Biomarker POCT Diagnostic Device Revenue by Manufacturer (2021-2026) & (USD Million)
Table 107. Global Cardiac Biomarker POCT Diagnostic Device Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 108. Market Position of Manufacturers in Cardiac Biomarker POCT Diagnostic Device, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 109. Head Office and Cardiac Biomarker POCT Diagnostic Device Production Site of Key Manufacturer
Table 110. Cardiac Biomarker POCT Diagnostic Device Market: Company Product Type Footprint
Table 111. Cardiac Biomarker POCT Diagnostic Device Market: Company Product Application Footprint
Table 112. Cardiac Biomarker POCT Diagnostic Device New Market Entrants and Barriers to Market Entry
Table 113. Cardiac Biomarker POCT Diagnostic Device Mergers, Acquisition, Agreements, and Collaborations
Table 114. Global Cardiac Biomarker POCT Diagnostic Device Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 115. Global Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Region (2021-2026) & (Units)
Table 116. Global Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Region (2027-2032) & (Units)
Table 117. Global Cardiac Biomarker POCT Diagnostic Device Consumption Value by Region (2021-2026) & (USD Million)
Table 118. Global Cardiac Biomarker POCT Diagnostic Device Consumption Value by Region (2027-2032) & (USD Million)
Table 119. Global Cardiac Biomarker POCT Diagnostic Device Average Price by Region (2021-2026) & (US$/Unit)
Table 120. Global Cardiac Biomarker POCT Diagnostic Device Average Price by Region (2027-2032) & (US$/Unit)
Table 121. Global Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Type (2021-2026) & (Units)
Table 122. Global Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Type (2027-2032) & (Units)
Table 123. Global Cardiac Biomarker POCT Diagnostic Device Consumption Value by Type (2021-2026) & (USD Million)
Table 124. Global Cardiac Biomarker POCT Diagnostic Device Consumption Value by Type (2027-2032) & (USD Million)
Table 125. Global Cardiac Biomarker POCT Diagnostic Device Average Price by Type (2021-2026) & (US$/Unit)
Table 126. Global Cardiac Biomarker POCT Diagnostic Device Average Price by Type (2027-2032) & (US$/Unit)
Table 127. Global Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Application (2021-2026) & (Units)
Table 128. Global Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Application (2027-2032) & (Units)
Table 129. Global Cardiac Biomarker POCT Diagnostic Device Consumption Value by Application (2021-2026) & (USD Million)
Table 130. Global Cardiac Biomarker POCT Diagnostic Device Consumption Value by Application (2027-2032) & (USD Million)
Table 131. Global Cardiac Biomarker POCT Diagnostic Device Average Price by Application (2021-2026) & (US$/Unit)
Table 132. Global Cardiac Biomarker POCT Diagnostic Device Average Price by Application (2027-2032) & (US$/Unit)
Table 133. North America Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Type (2021-2026) & (Units)
Table 134. North America Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Type (2027-2032) & (Units)
Table 135. North America Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Application (2021-2026) & (Units)
Table 136. North America Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Application (2027-2032) & (Units)
Table 137. North America Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Country (2021-2026) & (Units)
Table 138. North America Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Country (2027-2032) & (Units)
Table 139. North America Cardiac Biomarker POCT Diagnostic Device Consumption Value by Country (2021-2026) & (USD Million)
Table 140. North America Cardiac Biomarker POCT Diagnostic Device Consumption Value by Country (2027-2032) & (USD Million)
Table 141. Europe Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Type (2021-2026) & (Units)
Table 142. Europe Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Type (2027-2032) & (Units)
Table 143. Europe Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Application (2021-2026) & (Units)
Table 144. Europe Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Application (2027-2032) & (Units)
Table 145. Europe Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Country (2021-2026) & (Units)
Table 146. Europe Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Country (2027-2032) & (Units)
Table 147. Europe Cardiac Biomarker POCT Diagnostic Device Consumption Value by Country (2021-2026) & (USD Million)
Table 148. Europe Cardiac Biomarker POCT Diagnostic Device Consumption Value by Country (2027-2032) & (USD Million)
Table 149. Asia-Pacific Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Type (2021-2026) & (Units)
Table 150. Asia-Pacific Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Type (2027-2032) & (Units)
Table 151. Asia-Pacific Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Application (2021-2026) & (Units)
Table 152. Asia-Pacific Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Application (2027-2032) & (Units)
Table 153. Asia-Pacific Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Region (2021-2026) & (Units)
Table 154. Asia-Pacific Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Region (2027-2032) & (Units)
Table 155. Asia-Pacific Cardiac Biomarker POCT Diagnostic Device Consumption Value by Region (2021-2026) & (USD Million)
Table 156. Asia-Pacific Cardiac Biomarker POCT Diagnostic Device Consumption Value by Region (2027-2032) & (USD Million)
Table 157. South America Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Type (2021-2026) & (Units)
Table 158. South America Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Type (2027-2032) & (Units)
Table 159. South America Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Application (2021-2026) & (Units)
Table 160. South America Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Application (2027-2032) & (Units)
Table 161. South America Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Country (2021-2026) & (Units)
Table 162. South America Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Country (2027-2032) & (Units)
Table 163. South America Cardiac Biomarker POCT Diagnostic Device Consumption Value by Country (2021-2026) & (USD Million)
Table 164. South America Cardiac Biomarker POCT Diagnostic Device Consumption Value by Country (2027-2032) & (USD Million)
Table 165. Middle East & Africa Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Type (2021-2026) & (Units)
Table 166. Middle East & Africa Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Type (2027-2032) & (Units)
Table 167. Middle East & Africa Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Application (2021-2026) & (Units)
Table 168. Middle East & Africa Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Application (2027-2032) & (Units)
Table 169. Middle East & Africa Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Country (2021-2026) & (Units)
Table 170. Middle East & Africa Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Country (2027-2032) & (Units)
Table 171. Middle East & Africa Cardiac Biomarker POCT Diagnostic Device Consumption Value by Country (2021-2026) & (USD Million)
Table 172. Middle East & Africa Cardiac Biomarker POCT Diagnostic Device Consumption Value by Country (2027-2032) & (USD Million)
Table 173. Cardiac Biomarker POCT Diagnostic Device Raw Material
Table 174. Key Manufacturers of Cardiac Biomarker POCT Diagnostic Device Raw Materials
Table 175. Cardiac Biomarker POCT Diagnostic Device Typical Distributors
Table 176. Cardiac Biomarker POCT Diagnostic Device Typical Customers
Table 1. Global Cardiac Biomarker POCT Diagnostic Device Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Cardiac Biomarker POCT Diagnostic Device Consumption Value by Form, (USD Million), 2021 & 2025 & 2032
Table 3. Global Cardiac Biomarker POCT Diagnostic Device Consumption Value by Cardiac Biomarker, (USD Million), 2021 & 2025 & 2032
Table 4. Global Cardiac Biomarker POCT Diagnostic Device Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Roche Basic Information, Manufacturing Base and Competitors
Table 6. Roche Major Business
Table 7. Roche Cardiac Biomarker POCT Diagnostic Device Product and Services
Table 8. Roche Cardiac Biomarker POCT Diagnostic Device Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. Roche Recent Developments/Updates
Table 10. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 11. Abbott Laboratories Major Business
Table 12. Abbott Laboratories Cardiac Biomarker POCT Diagnostic Device Product and Services
Table 13. Abbott Laboratories Cardiac Biomarker POCT Diagnostic Device Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. Abbott Laboratories Recent Developments/Updates
Table 15. QuidelOrtho Corporation Basic Information, Manufacturing Base and Competitors
Table 16. QuidelOrtho Corporation Major Business
Table 17. QuidelOrtho Corporation Cardiac Biomarker POCT Diagnostic Device Product and Services
Table 18. QuidelOrtho Corporation Cardiac Biomarker POCT Diagnostic Device Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 19. QuidelOrtho Corporation Recent Developments/Updates
Table 20. Radiometer Medical Basic Information, Manufacturing Base and Competitors
Table 21. Radiometer Medical Major Business
Table 22. Radiometer Medical Cardiac Biomarker POCT Diagnostic Device Product and Services
Table 23. Radiometer Medical Cardiac Biomarker POCT Diagnostic Device Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 24. Radiometer Medical Recent Developments/Updates
Table 25. Siemens Healthineers Basic Information, Manufacturing Base and Competitors
Table 26. Siemens Healthineers Major Business
Table 27. Siemens Healthineers Cardiac Biomarker POCT Diagnostic Device Product and Services
Table 28. Siemens Healthineers Cardiac Biomarker POCT Diagnostic Device Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 29. Siemens Healthineers Recent Developments/Updates
Table 30. PHC Holdings Basic Information, Manufacturing Base and Competitors
Table 31. PHC Holdings Major Business
Table 32. PHC Holdings Cardiac Biomarker POCT Diagnostic Device Product and Services
Table 33. PHC Holdings Cardiac Biomarker POCT Diagnostic Device Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 34. PHC Holdings Recent Developments/Updates
Table 35. Guangzhou Wondfo Biotech Basic Information, Manufacturing Base and Competitors
Table 36. Guangzhou Wondfo Biotech Major Business
Table 37. Guangzhou Wondfo Biotech Cardiac Biomarker POCT Diagnostic Device Product and Services
Table 38. Guangzhou Wondfo Biotech Cardiac Biomarker POCT Diagnostic Device Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 39. Guangzhou Wondfo Biotech Recent Developments/Updates
Table 40. Getein Biotech Basic Information, Manufacturing Base and Competitors
Table 41. Getein Biotech Major Business
Table 42. Getein Biotech Cardiac Biomarker POCT Diagnostic Device Product and Services
Table 43. Getein Biotech Cardiac Biomarker POCT Diagnostic Device Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 44. Getein Biotech Recent Developments/Updates
Table 45. Boditech Med Basic Information, Manufacturing Base and Competitors
Table 46. Boditech Med Major Business
Table 47. Boditech Med Cardiac Biomarker POCT Diagnostic Device Product and Services
Table 48. Boditech Med Cardiac Biomarker POCT Diagnostic Device Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 49. Boditech Med Recent Developments/Updates
Table 50. SD BIOSENSOR Basic Information, Manufacturing Base and Competitors
Table 51. SD BIOSENSOR Major Business
Table 52. SD BIOSENSOR Cardiac Biomarker POCT Diagnostic Device Product and Services
Table 53. SD BIOSENSOR Cardiac Biomarker POCT Diagnostic Device Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 54. SD BIOSENSOR Recent Developments/Updates
Table 55. Lepu Medical Technology Basic Information, Manufacturing Base and Competitors
Table 56. Lepu Medical Technology Major Business
Table 57. Lepu Medical Technology Cardiac Biomarker POCT Diagnostic Device Product and Services
Table 58. Lepu Medical Technology Cardiac Biomarker POCT Diagnostic Device Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 59. Lepu Medical Technology Recent Developments/Updates
Table 60. Humasis Basic Information, Manufacturing Base and Competitors
Table 61. Humasis Major Business
Table 62. Humasis Cardiac Biomarker POCT Diagnostic Device Product and Services
Table 63. Humasis Cardiac Biomarker POCT Diagnostic Device Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 64. Humasis Recent Developments/Updates
Table 65. NanoEntek Basic Information, Manufacturing Base and Competitors
Table 66. NanoEntek Major Business
Table 67. NanoEntek Cardiac Biomarker POCT Diagnostic Device Product and Services
Table 68. NanoEntek Cardiac Biomarker POCT Diagnostic Device Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 69. NanoEntek Recent Developments/Updates
Table 70. Xiamen Biotime Biotechnology Basic Information, Manufacturing Base and Competitors
Table 71. Xiamen Biotime Biotechnology Major Business
Table 72. Xiamen Biotime Biotechnology Cardiac Biomarker POCT Diagnostic Device Product and Services
Table 73. Xiamen Biotime Biotechnology Cardiac Biomarker POCT Diagnostic Device Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 74. Xiamen Biotime Biotechnology Recent Developments/Updates
Table 75. Nanjing Lansion Biotechnology Basic Information, Manufacturing Base and Competitors
Table 76. Nanjing Lansion Biotechnology Major Business
Table 77. Nanjing Lansion Biotechnology Cardiac Biomarker POCT Diagnostic Device Product and Services
Table 78. Nanjing Lansion Biotechnology Cardiac Biomarker POCT Diagnostic Device Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Nanjing Lansion Biotechnology Recent Developments/Updates
Table 80. Shenzhen Micropoint Biotechnologies Basic Information, Manufacturing Base and Competitors
Table 81. Shenzhen Micropoint Biotechnologies Major Business
Table 82. Shenzhen Micropoint Biotechnologies Cardiac Biomarker POCT Diagnostic Device Product and Services
Table 83. Shenzhen Micropoint Biotechnologies Cardiac Biomarker POCT Diagnostic Device Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 84. Shenzhen Micropoint Biotechnologies Recent Developments/Updates
Table 85. Shijiazhuang Hipro Biotechnology Basic Information, Manufacturing Base and Competitors
Table 86. Shijiazhuang Hipro Biotechnology Major Business
Table 87. Shijiazhuang Hipro Biotechnology Cardiac Biomarker POCT Diagnostic Device Product and Services
Table 88. Shijiazhuang Hipro Biotechnology Cardiac Biomarker POCT Diagnostic Device Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 89. Shijiazhuang Hipro Biotechnology Recent Developments/Updates
Table 90. AEHEALTH Basic Information, Manufacturing Base and Competitors
Table 91. AEHEALTH Major Business
Table 92. AEHEALTH Cardiac Biomarker POCT Diagnostic Device Product and Services
Table 93. AEHEALTH Cardiac Biomarker POCT Diagnostic Device Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 94. AEHEALTH Recent Developments/Updates
Table 95. Guangzhou KOFA Biotechnology Basic Information, Manufacturing Base and Competitors
Table 96. Guangzhou KOFA Biotechnology Major Business
Table 97. Guangzhou KOFA Biotechnology Cardiac Biomarker POCT Diagnostic Device Product and Services
Table 98. Guangzhou KOFA Biotechnology Cardiac Biomarker POCT Diagnostic Device Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 99. Guangzhou KOFA Biotechnology Recent Developments/Updates
Table 100. Response Biomedical Basic Information, Manufacturing Base and Competitors
Table 101. Response Biomedical Major Business
Table 102. Response Biomedical Cardiac Biomarker POCT Diagnostic Device Product and Services
Table 103. Response Biomedical Cardiac Biomarker POCT Diagnostic Device Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 104. Response Biomedical Recent Developments/Updates
Table 105. Global Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Manufacturer (2021-2026) & (Units)
Table 106. Global Cardiac Biomarker POCT Diagnostic Device Revenue by Manufacturer (2021-2026) & (USD Million)
Table 107. Global Cardiac Biomarker POCT Diagnostic Device Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 108. Market Position of Manufacturers in Cardiac Biomarker POCT Diagnostic Device, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 109. Head Office and Cardiac Biomarker POCT Diagnostic Device Production Site of Key Manufacturer
Table 110. Cardiac Biomarker POCT Diagnostic Device Market: Company Product Type Footprint
Table 111. Cardiac Biomarker POCT Diagnostic Device Market: Company Product Application Footprint
Table 112. Cardiac Biomarker POCT Diagnostic Device New Market Entrants and Barriers to Market Entry
Table 113. Cardiac Biomarker POCT Diagnostic Device Mergers, Acquisition, Agreements, and Collaborations
Table 114. Global Cardiac Biomarker POCT Diagnostic Device Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 115. Global Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Region (2021-2026) & (Units)
Table 116. Global Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Region (2027-2032) & (Units)
Table 117. Global Cardiac Biomarker POCT Diagnostic Device Consumption Value by Region (2021-2026) & (USD Million)
Table 118. Global Cardiac Biomarker POCT Diagnostic Device Consumption Value by Region (2027-2032) & (USD Million)
Table 119. Global Cardiac Biomarker POCT Diagnostic Device Average Price by Region (2021-2026) & (US$/Unit)
Table 120. Global Cardiac Biomarker POCT Diagnostic Device Average Price by Region (2027-2032) & (US$/Unit)
Table 121. Global Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Type (2021-2026) & (Units)
Table 122. Global Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Type (2027-2032) & (Units)
Table 123. Global Cardiac Biomarker POCT Diagnostic Device Consumption Value by Type (2021-2026) & (USD Million)
Table 124. Global Cardiac Biomarker POCT Diagnostic Device Consumption Value by Type (2027-2032) & (USD Million)
Table 125. Global Cardiac Biomarker POCT Diagnostic Device Average Price by Type (2021-2026) & (US$/Unit)
Table 126. Global Cardiac Biomarker POCT Diagnostic Device Average Price by Type (2027-2032) & (US$/Unit)
Table 127. Global Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Application (2021-2026) & (Units)
Table 128. Global Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Application (2027-2032) & (Units)
Table 129. Global Cardiac Biomarker POCT Diagnostic Device Consumption Value by Application (2021-2026) & (USD Million)
Table 130. Global Cardiac Biomarker POCT Diagnostic Device Consumption Value by Application (2027-2032) & (USD Million)
Table 131. Global Cardiac Biomarker POCT Diagnostic Device Average Price by Application (2021-2026) & (US$/Unit)
Table 132. Global Cardiac Biomarker POCT Diagnostic Device Average Price by Application (2027-2032) & (US$/Unit)
Table 133. North America Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Type (2021-2026) & (Units)
Table 134. North America Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Type (2027-2032) & (Units)
Table 135. North America Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Application (2021-2026) & (Units)
Table 136. North America Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Application (2027-2032) & (Units)
Table 137. North America Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Country (2021-2026) & (Units)
Table 138. North America Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Country (2027-2032) & (Units)
Table 139. North America Cardiac Biomarker POCT Diagnostic Device Consumption Value by Country (2021-2026) & (USD Million)
Table 140. North America Cardiac Biomarker POCT Diagnostic Device Consumption Value by Country (2027-2032) & (USD Million)
Table 141. Europe Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Type (2021-2026) & (Units)
Table 142. Europe Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Type (2027-2032) & (Units)
Table 143. Europe Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Application (2021-2026) & (Units)
Table 144. Europe Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Application (2027-2032) & (Units)
Table 145. Europe Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Country (2021-2026) & (Units)
Table 146. Europe Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Country (2027-2032) & (Units)
Table 147. Europe Cardiac Biomarker POCT Diagnostic Device Consumption Value by Country (2021-2026) & (USD Million)
Table 148. Europe Cardiac Biomarker POCT Diagnostic Device Consumption Value by Country (2027-2032) & (USD Million)
Table 149. Asia-Pacific Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Type (2021-2026) & (Units)
Table 150. Asia-Pacific Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Type (2027-2032) & (Units)
Table 151. Asia-Pacific Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Application (2021-2026) & (Units)
Table 152. Asia-Pacific Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Application (2027-2032) & (Units)
Table 153. Asia-Pacific Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Region (2021-2026) & (Units)
Table 154. Asia-Pacific Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Region (2027-2032) & (Units)
Table 155. Asia-Pacific Cardiac Biomarker POCT Diagnostic Device Consumption Value by Region (2021-2026) & (USD Million)
Table 156. Asia-Pacific Cardiac Biomarker POCT Diagnostic Device Consumption Value by Region (2027-2032) & (USD Million)
Table 157. South America Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Type (2021-2026) & (Units)
Table 158. South America Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Type (2027-2032) & (Units)
Table 159. South America Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Application (2021-2026) & (Units)
Table 160. South America Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Application (2027-2032) & (Units)
Table 161. South America Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Country (2021-2026) & (Units)
Table 162. South America Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Country (2027-2032) & (Units)
Table 163. South America Cardiac Biomarker POCT Diagnostic Device Consumption Value by Country (2021-2026) & (USD Million)
Table 164. South America Cardiac Biomarker POCT Diagnostic Device Consumption Value by Country (2027-2032) & (USD Million)
Table 165. Middle East & Africa Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Type (2021-2026) & (Units)
Table 166. Middle East & Africa Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Type (2027-2032) & (Units)
Table 167. Middle East & Africa Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Application (2021-2026) & (Units)
Table 168. Middle East & Africa Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Application (2027-2032) & (Units)
Table 169. Middle East & Africa Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Country (2021-2026) & (Units)
Table 170. Middle East & Africa Cardiac Biomarker POCT Diagnostic Device Sales Quantity by Country (2027-2032) & (Units)
Table 171. Middle East & Africa Cardiac Biomarker POCT Diagnostic Device Consumption Value by Country (2021-2026) & (USD Million)
Table 172. Middle East & Africa Cardiac Biomarker POCT Diagnostic Device Consumption Value by Country (2027-2032) & (USD Million)
Table 173. Cardiac Biomarker POCT Diagnostic Device Raw Material
Table 174. Key Manufacturers of Cardiac Biomarker POCT Diagnostic Device Raw Materials
Table 175. Cardiac Biomarker POCT Diagnostic Device Typical Distributors
Table 176. Cardiac Biomarker POCT Diagnostic Device Typical Customers
LIST OF FIGURES
Figure 1. Cardiac Biomarker POCT Diagnostic Device Picture
Figure 2. Global Cardiac Biomarker POCT Diagnostic Device Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Cardiac Biomarker POCT Diagnostic Device Revenue Market Share by Type in 2025
Figure 4. Fluorescence Immunoassay Examples
Figure 5. Chemiluminescence Immunoassay Examples
Figure 6. Other Examples
Figure 7. Global Cardiac Biomarker POCT Diagnostic Device Revenue by Form, (USD Million), 2021 & 2025 & 2032
Figure 8. Global Cardiac Biomarker POCT Diagnostic Device Revenue Market Share by Form in 2025
Figure 9. Handheld Examples
Figure 10. Benchtop Examples
Figure 11. Other Examples
Figure 12. Global Cardiac Biomarker POCT Diagnostic Device Revenue by Cardiac Biomarker, (USD Million), 2021 & 2025 & 2032
Figure 13. Global Cardiac Biomarker POCT Diagnostic Device Revenue Market Share by Cardiac Biomarker in 2025
Figure 14. Troponin-focused Examples
Figure 15. Natriuretic Peptide-focused Examples
Figure 16. Other Examples
Figure 17. Global Cardiac Biomarker POCT Diagnostic Device Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 18. Global Cardiac Biomarker POCT Diagnostic Device Revenue Market Share by Application in 2025
Figure 19. Hospital Examples
Figure 20. Clinic Examples
Figure 21. Others Examples
Figure 22. Global Cardiac Biomarker POCT Diagnostic Device Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 23. Global Cardiac Biomarker POCT Diagnostic Device Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 24. Global Cardiac Biomarker POCT Diagnostic Device Sales Quantity (2021-2032) & (Units)
Figure 25. Global Cardiac Biomarker POCT Diagnostic Device Price (2021-2032) & (US$/Unit)
Figure 26. Global Cardiac Biomarker POCT Diagnostic Device Sales Quantity Market Share by Manufacturer in 2025
Figure 27. Global Cardiac Biomarker POCT Diagnostic Device Revenue Market Share by Manufacturer in 2025
Figure 28. Producer Shipments of Cardiac Biomarker POCT Diagnostic Device by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 29. Top 3 Cardiac Biomarker POCT Diagnostic Device Manufacturer (Revenue) Market Share in 2025
Figure 30. Top 6 Cardiac Biomarker POCT Diagnostic Device Manufacturer (Revenue) Market Share in 2025
Figure 31. Global Cardiac Biomarker POCT Diagnostic Device Sales Quantity Market Share by Region (2021-2032)
Figure 32. Global Cardiac Biomarker POCT Diagnostic Device Consumption Value Market Share by Region (2021-2032)
Figure 33. North America Cardiac Biomarker POCT Diagnostic Device Consumption Value (2021-2032) & (USD Million)
Figure 34. Europe Cardiac Biomarker POCT Diagnostic Device Consumption Value (2021-2032) & (USD Million)
Figure 35. Asia-Pacific Cardiac Biomarker POCT Diagnostic Device Consumption Value (2021-2032) & (USD Million)
Figure 36. South America Cardiac Biomarker POCT Diagnostic Device Consumption Value (2021-2032) & (USD Million)
Figure 37. Middle East & Africa Cardiac Biomarker POCT Diagnostic Device Consumption Value (2021-2032) & (USD Million)
Figure 38. Global Cardiac Biomarker POCT Diagnostic Device Sales Quantity Market Share by Type (2021-2032)
Figure 39. Global Cardiac Biomarker POCT Diagnostic Device Consumption Value Market Share by Type (2021-2032)
Figure 40. Global Cardiac Biomarker POCT Diagnostic Device Average Price by Type (2021-2032) & (US$/Unit)
Figure 41. Global Cardiac Biomarker POCT Diagnostic Device Sales Quantity Market Share by Application (2021-2032)
Figure 42. Global Cardiac Biomarker POCT Diagnostic Device Revenue Market Share by Application (2021-2032)
Figure 43. Global Cardiac Biomarker POCT Diagnostic Device Average Price by Application (2021-2032) & (US$/Unit)
Figure 44. North America Cardiac Biomarker POCT Diagnostic Device Sales Quantity Market Share by Type (2021-2032)
Figure 45. North America Cardiac Biomarker POCT Diagnostic Device Sales Quantity Market Share by Application (2021-2032)
Figure 46. North America Cardiac Biomarker POCT Diagnostic Device Sales Quantity Market Share by Country (2021-2032)
Figure 47. North America Cardiac Biomarker POCT Diagnostic Device Consumption Value Market Share by Country (2021-2032)
Figure 48. United States Cardiac Biomarker POCT Diagnostic Device Consumption Value (2021-2032) & (USD Million)
Figure 49. Canada Cardiac Biomarker POCT Diagnostic Device Consumption Value (2021-2032) & (USD Million)
Figure 50. Mexico Cardiac Biomarker POCT Diagnostic Device Consumption Value (2021-2032) & (USD Million)
Figure 51. Europe Cardiac Biomarker POCT Diagnostic Device Sales Quantity Market Share by Type (2021-2032)
Figure 52. Europe Cardiac Biomarker POCT Diagnostic Device Sales Quantity Market Share by Application (2021-2032)
Figure 53. Europe Cardiac Biomarker POCT Diagnostic Device Sales Quantity Market Share by Country (2021-2032)
Figure 54. Europe Cardiac Biomarker POCT Diagnostic Device Consumption Value Market Share by Country (2021-2032)
Figure 55. Germany Cardiac Biomarker POCT Diagnostic Device Consumption Value (2021-2032) & (USD Million)
Figure 56. France Cardiac Biomarker POCT Diagnostic Device Consumption Value (2021-2032) & (USD Million)
Figure 57. United Kingdom Cardiac Biomarker POCT Diagnostic Device Consumption Value (2021-2032) & (USD Million)
Figure 58. Russia Cardiac Biomarker POCT Diagnostic Device Consumption Value (2021-2032) & (USD Million)
Figure 59. Italy Cardiac Biomarker POCT Diagnostic Device Consumption Value (2021-2032) & (USD Million)
Figure 60. Asia-Pacific Cardiac Biomarker POCT Diagnostic Device Sales Quantity Market Share by Type (2021-2032)
Figure 61. Asia-Pacific Cardiac Biomarker POCT Diagnostic Device Sales Quantity Market Share by Application (2021-2032)
Figure 62. Asia-Pacific Cardiac Biomarker POCT Diagnostic Device Sales Quantity Market Share by Region (2021-2032)
Figure 63. Asia-Pacific Cardiac Biomarker POCT Diagnostic Device Consumption Value Market Share by Region (2021-2032)
Figure 64. China Cardiac Biomarker POCT Diagnostic Device Consumption Value (2021-2032) & (USD Million)
Figure 65. Japan Cardiac Biomarker POCT Diagnostic Device Consumption Value (2021-2032) & (USD Million)
Figure 66. South Korea Cardiac Biomarker POCT Diagnostic Device Consumption Value (2021-2032) & (USD Million)
Figure 67. India Cardiac Biomarker POCT Diagnostic Device Consumption Value (2021-2032) & (USD Million)
Figure 68. Southeast Asia Cardiac Biomarker POCT Diagnostic Device Consumption Value (2021-2032) & (USD Million)
Figure 69. Australia Cardiac Biomarker POCT Diagnostic Device Consumption Value (2021-2032) & (USD Million)
Figure 70. South America Cardiac Biomarker POCT Diagnostic Device Sales Quantity Market Share by Type (2021-2032)
Figure 71. South America Cardiac Biomarker POCT Diagnostic Device Sales Quantity Market Share by Application (2021-2032)
Figure 72. South America Cardiac Biomarker POCT Diagnostic Device Sales Quantity Market Share by Country (2021-2032)
Figure 73. South America Cardiac Biomarker POCT Diagnostic Device Consumption Value Market Share by Country (2021-2032)
Figure 74. Brazil Cardiac Biomarker POCT Diagnostic Device Consumption Value (2021-2032) & (USD Million)
Figure 75. Argentina Cardiac Biomarker POCT Diagnostic Device Consumption Value (2021-2032) & (USD Million)
Figure 76. Middle East & Africa Cardiac Biomarker POCT Diagnostic Device Sales Quantity Market Share by Type (2021-2032)
Figure 77. Middle East & Africa Cardiac Biomarker POCT Diagnostic Device Sales Quantity Market Share by Application (2021-2032)
Figure 78. Middle East & Africa Cardiac Biomarker POCT Diagnostic Device Sales Quantity Market Share by Country (2021-2032)
Figure 79. Middle East & Africa Cardiac Biomarker POCT Diagnostic Device Consumption Value Market Share by Country (2021-2032)
Figure 80. Turkey Cardiac Biomarker POCT Diagnostic Device Consumption Value (2021-2032) & (USD Million)
Figure 81. Egypt Cardiac Biomarker POCT Diagnostic Device Consumption Value (2021-2032) & (USD Million)
Figure 82. Saudi Arabia Cardiac Biomarker POCT Diagnostic Device Consumption Value (2021-2032) & (USD Million)
Figure 83. South Africa Cardiac Biomarker POCT Diagnostic Device Consumption Value (2021-2032) & (USD Million)
Figure 84. Cardiac Biomarker POCT Diagnostic Device Market Drivers
Figure 85. Cardiac Biomarker POCT Diagnostic Device Market Restraints
Figure 86. Cardiac Biomarker POCT Diagnostic Device Market Trends
Figure 87. Porters Five Forces Analysis
Figure 88. Manufacturing Cost Structure Analysis of Cardiac Biomarker POCT Diagnostic Device in 2025
Figure 89. Manufacturing Process Analysis of Cardiac Biomarker POCT Diagnostic Device
Figure 90. Cardiac Biomarker POCT Diagnostic Device Industrial Chain
Figure 91. Sales Channel: Direct to End-User vs Distributors
Figure 92. Direct Channel Pros & Cons
Figure 93. Indirect Channel Pros & Cons
Figure 94. Methodology
Figure 95. Research Process and Data Source
Figure 1. Cardiac Biomarker POCT Diagnostic Device Picture
Figure 2. Global Cardiac Biomarker POCT Diagnostic Device Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Cardiac Biomarker POCT Diagnostic Device Revenue Market Share by Type in 2025
Figure 4. Fluorescence Immunoassay Examples
Figure 5. Chemiluminescence Immunoassay Examples
Figure 6. Other Examples
Figure 7. Global Cardiac Biomarker POCT Diagnostic Device Revenue by Form, (USD Million), 2021 & 2025 & 2032
Figure 8. Global Cardiac Biomarker POCT Diagnostic Device Revenue Market Share by Form in 2025
Figure 9. Handheld Examples
Figure 10. Benchtop Examples
Figure 11. Other Examples
Figure 12. Global Cardiac Biomarker POCT Diagnostic Device Revenue by Cardiac Biomarker, (USD Million), 2021 & 2025 & 2032
Figure 13. Global Cardiac Biomarker POCT Diagnostic Device Revenue Market Share by Cardiac Biomarker in 2025
Figure 14. Troponin-focused Examples
Figure 15. Natriuretic Peptide-focused Examples
Figure 16. Other Examples
Figure 17. Global Cardiac Biomarker POCT Diagnostic Device Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 18. Global Cardiac Biomarker POCT Diagnostic Device Revenue Market Share by Application in 2025
Figure 19. Hospital Examples
Figure 20. Clinic Examples
Figure 21. Others Examples
Figure 22. Global Cardiac Biomarker POCT Diagnostic Device Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 23. Global Cardiac Biomarker POCT Diagnostic Device Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 24. Global Cardiac Biomarker POCT Diagnostic Device Sales Quantity (2021-2032) & (Units)
Figure 25. Global Cardiac Biomarker POCT Diagnostic Device Price (2021-2032) & (US$/Unit)
Figure 26. Global Cardiac Biomarker POCT Diagnostic Device Sales Quantity Market Share by Manufacturer in 2025
Figure 27. Global Cardiac Biomarker POCT Diagnostic Device Revenue Market Share by Manufacturer in 2025
Figure 28. Producer Shipments of Cardiac Biomarker POCT Diagnostic Device by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 29. Top 3 Cardiac Biomarker POCT Diagnostic Device Manufacturer (Revenue) Market Share in 2025
Figure 30. Top 6 Cardiac Biomarker POCT Diagnostic Device Manufacturer (Revenue) Market Share in 2025
Figure 31. Global Cardiac Biomarker POCT Diagnostic Device Sales Quantity Market Share by Region (2021-2032)
Figure 32. Global Cardiac Biomarker POCT Diagnostic Device Consumption Value Market Share by Region (2021-2032)
Figure 33. North America Cardiac Biomarker POCT Diagnostic Device Consumption Value (2021-2032) & (USD Million)
Figure 34. Europe Cardiac Biomarker POCT Diagnostic Device Consumption Value (2021-2032) & (USD Million)
Figure 35. Asia-Pacific Cardiac Biomarker POCT Diagnostic Device Consumption Value (2021-2032) & (USD Million)
Figure 36. South America Cardiac Biomarker POCT Diagnostic Device Consumption Value (2021-2032) & (USD Million)
Figure 37. Middle East & Africa Cardiac Biomarker POCT Diagnostic Device Consumption Value (2021-2032) & (USD Million)
Figure 38. Global Cardiac Biomarker POCT Diagnostic Device Sales Quantity Market Share by Type (2021-2032)
Figure 39. Global Cardiac Biomarker POCT Diagnostic Device Consumption Value Market Share by Type (2021-2032)
Figure 40. Global Cardiac Biomarker POCT Diagnostic Device Average Price by Type (2021-2032) & (US$/Unit)
Figure 41. Global Cardiac Biomarker POCT Diagnostic Device Sales Quantity Market Share by Application (2021-2032)
Figure 42. Global Cardiac Biomarker POCT Diagnostic Device Revenue Market Share by Application (2021-2032)
Figure 43. Global Cardiac Biomarker POCT Diagnostic Device Average Price by Application (2021-2032) & (US$/Unit)
Figure 44. North America Cardiac Biomarker POCT Diagnostic Device Sales Quantity Market Share by Type (2021-2032)
Figure 45. North America Cardiac Biomarker POCT Diagnostic Device Sales Quantity Market Share by Application (2021-2032)
Figure 46. North America Cardiac Biomarker POCT Diagnostic Device Sales Quantity Market Share by Country (2021-2032)
Figure 47. North America Cardiac Biomarker POCT Diagnostic Device Consumption Value Market Share by Country (2021-2032)
Figure 48. United States Cardiac Biomarker POCT Diagnostic Device Consumption Value (2021-2032) & (USD Million)
Figure 49. Canada Cardiac Biomarker POCT Diagnostic Device Consumption Value (2021-2032) & (USD Million)
Figure 50. Mexico Cardiac Biomarker POCT Diagnostic Device Consumption Value (2021-2032) & (USD Million)
Figure 51. Europe Cardiac Biomarker POCT Diagnostic Device Sales Quantity Market Share by Type (2021-2032)
Figure 52. Europe Cardiac Biomarker POCT Diagnostic Device Sales Quantity Market Share by Application (2021-2032)
Figure 53. Europe Cardiac Biomarker POCT Diagnostic Device Sales Quantity Market Share by Country (2021-2032)
Figure 54. Europe Cardiac Biomarker POCT Diagnostic Device Consumption Value Market Share by Country (2021-2032)
Figure 55. Germany Cardiac Biomarker POCT Diagnostic Device Consumption Value (2021-2032) & (USD Million)
Figure 56. France Cardiac Biomarker POCT Diagnostic Device Consumption Value (2021-2032) & (USD Million)
Figure 57. United Kingdom Cardiac Biomarker POCT Diagnostic Device Consumption Value (2021-2032) & (USD Million)
Figure 58. Russia Cardiac Biomarker POCT Diagnostic Device Consumption Value (2021-2032) & (USD Million)
Figure 59. Italy Cardiac Biomarker POCT Diagnostic Device Consumption Value (2021-2032) & (USD Million)
Figure 60. Asia-Pacific Cardiac Biomarker POCT Diagnostic Device Sales Quantity Market Share by Type (2021-2032)
Figure 61. Asia-Pacific Cardiac Biomarker POCT Diagnostic Device Sales Quantity Market Share by Application (2021-2032)
Figure 62. Asia-Pacific Cardiac Biomarker POCT Diagnostic Device Sales Quantity Market Share by Region (2021-2032)
Figure 63. Asia-Pacific Cardiac Biomarker POCT Diagnostic Device Consumption Value Market Share by Region (2021-2032)
Figure 64. China Cardiac Biomarker POCT Diagnostic Device Consumption Value (2021-2032) & (USD Million)
Figure 65. Japan Cardiac Biomarker POCT Diagnostic Device Consumption Value (2021-2032) & (USD Million)
Figure 66. South Korea Cardiac Biomarker POCT Diagnostic Device Consumption Value (2021-2032) & (USD Million)
Figure 67. India Cardiac Biomarker POCT Diagnostic Device Consumption Value (2021-2032) & (USD Million)
Figure 68. Southeast Asia Cardiac Biomarker POCT Diagnostic Device Consumption Value (2021-2032) & (USD Million)
Figure 69. Australia Cardiac Biomarker POCT Diagnostic Device Consumption Value (2021-2032) & (USD Million)
Figure 70. South America Cardiac Biomarker POCT Diagnostic Device Sales Quantity Market Share by Type (2021-2032)
Figure 71. South America Cardiac Biomarker POCT Diagnostic Device Sales Quantity Market Share by Application (2021-2032)
Figure 72. South America Cardiac Biomarker POCT Diagnostic Device Sales Quantity Market Share by Country (2021-2032)
Figure 73. South America Cardiac Biomarker POCT Diagnostic Device Consumption Value Market Share by Country (2021-2032)
Figure 74. Brazil Cardiac Biomarker POCT Diagnostic Device Consumption Value (2021-2032) & (USD Million)
Figure 75. Argentina Cardiac Biomarker POCT Diagnostic Device Consumption Value (2021-2032) & (USD Million)
Figure 76. Middle East & Africa Cardiac Biomarker POCT Diagnostic Device Sales Quantity Market Share by Type (2021-2032)
Figure 77. Middle East & Africa Cardiac Biomarker POCT Diagnostic Device Sales Quantity Market Share by Application (2021-2032)
Figure 78. Middle East & Africa Cardiac Biomarker POCT Diagnostic Device Sales Quantity Market Share by Country (2021-2032)
Figure 79. Middle East & Africa Cardiac Biomarker POCT Diagnostic Device Consumption Value Market Share by Country (2021-2032)
Figure 80. Turkey Cardiac Biomarker POCT Diagnostic Device Consumption Value (2021-2032) & (USD Million)
Figure 81. Egypt Cardiac Biomarker POCT Diagnostic Device Consumption Value (2021-2032) & (USD Million)
Figure 82. Saudi Arabia Cardiac Biomarker POCT Diagnostic Device Consumption Value (2021-2032) & (USD Million)
Figure 83. South Africa Cardiac Biomarker POCT Diagnostic Device Consumption Value (2021-2032) & (USD Million)
Figure 84. Cardiac Biomarker POCT Diagnostic Device Market Drivers
Figure 85. Cardiac Biomarker POCT Diagnostic Device Market Restraints
Figure 86. Cardiac Biomarker POCT Diagnostic Device Market Trends
Figure 87. Porters Five Forces Analysis
Figure 88. Manufacturing Cost Structure Analysis of Cardiac Biomarker POCT Diagnostic Device in 2025
Figure 89. Manufacturing Process Analysis of Cardiac Biomarker POCT Diagnostic Device
Figure 90. Cardiac Biomarker POCT Diagnostic Device Industrial Chain
Figure 91. Sales Channel: Direct to End-User vs Distributors
Figure 92. Direct Channel Pros & Cons
Figure 93. Indirect Channel Pros & Cons
Figure 94. Methodology
Figure 95. Research Process and Data Source
